News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Illumina, Inc. (ILMN) Plans Poison Pill to Thwart Roche (RHHBY) Bid


1/26/2012 8:09:22 AM

Illumina Inc. (ILMN) adopted a so-called poison-pill takeover defense after Roche Holding AG (ROG) made a hostile $5.7 billion bid for the maker of gene-mapping equipment. Shareholders will receive one preferred stock purchase right as a dividend for each common share held as of the close of business Feb. 6, San Diego-based Illumina said in a statement today. The rights won’t be exercisable initially, Illumina said. Such a rights agreement can block a hostile bid by making it prohibitively expensive. Should Roche or another bidder become the owner of 15 percent or more of Illumina’s stock, other shareholders will be able to exercise the rights to buy new common stock, diluting the stake of the prospective bidder.

Read at Bloomberg
Read at Wall Street Journal
Read at Washington Post
Read at Reuters


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES